Symmetry Partners’s Chemours CC Stock Holding History

Symmetry Partners’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,040	Closed	-$451K	–	543
2023 Q4	$451K	Hold	14,040	–	–	0.02%	309
2023 Q3	$394K	Hold	14,040	–	–	0.02%	369
2023 Q2	$518K	Hold	14,040	–	–	0.03%	328
2023 Q1	$420K	Hold	14,040	–	–	0.02%	374
2022 Q4	$430K	Hold	14,040	–	–	0.03%	368
2022 Q3	$346K	Hold	14,040	–	–	0.02%	400
2022 Q2	$450K	Hold	14,040	–	–	0.03%	345
2022 Q1	$442K	Sell	14,040 -20,033	-59%	-$627K	0.03%	392
2021 Q4	$1.14M	Sell	34,073 -1,815	-5%	-$56.5K	0.07%	180
2021 Q3	$1.09M	Hold	35,888	–	–	0.07%	202
2021 Q2	$1.25M	Hold	35,888	–	–	0.08%	174
2021 Q1	$1M	Buy	35,888 +8,085	+29%	+$215K	0.07%	197
2020 Q4	$689K	Buy	27,803 +6,334	+30%	+$151K	0.05%	274
2020 Q3	$449K	Buy	+21,469	New	+$414K	0.04%	363

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Symmetry Partners's CC Position: Q1 2024 in Review

Symmetry Partners sold out of Chemours (CC) in Q1 2024, closing a stake of 14,040 shares — an estimated $451K sold.

Symmetry Partners first reported a position in CC in Q3 2020 and held it in 14 quarters. The position peaked at $1.25M in Q2 2021. 444 funds tracked by Wall St. Rank hold CC as of Q1 2024.

Symmetry Partners reported no remaining Chemours position as of Q1 2024 after selling out during the quarter.
Symmetry Partners sold 14,040 Chemours shares in Q1 2024, an estimated $451K.
Symmetry Partners first reported a position in Chemours in Q3 2020 and held it in 14 quarters.
Symmetry Partners's Chemours position peaked at $1.25M in Q2 2021.
444 funds tracked by Wall St. Rank held Chemours as of Q1 2024.

Based on Symmetry Partners's 13F filing for Q1 2024, filed 2 Apr 2024.